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For ten years, the incidence of preterm birth does not decrease in developed countries despite the promotion of public health
programs. Many risk factors have been identiﬁed including ethnicity, age, tobacco, and infection. However, almost 50% of
preterm birth causes remain unknown. The periodontal diseases are highly prevalent inﬂammatory and infectious diseases
of tooth supporting tissues leading to an oral disability. They inﬂuence negatively general health worsening cardiovascular
diseases and diabetes. Periodontal diseases have been also suspected to increase the rate of preterm birth, but data remain
contradictory. The objective of this review is to present the principal results of epidemiological, biological, and interventional
studies on the link between periodontal diseases and preterm birth. The conclusions of this work underline the importance for
the physician/obstetrician to identify women at risk for preterm birth and to address these patients to dentist for periodontal
examination and treatment in order to limit adverse pregnancy outcomes.
1.Introduction
Preterm birth is deﬁned as any delivery that occurs after
23 gestational weeks and less than 37 weeks [1, 2]. This is
a major determinant of neonatal morbidity and mortality
[3]. Furthermore, preterm birth has long-term consequences
for infant including an increased risk of neurological
impairments and behavior disorders and higher rates of
chronic health disorders than children born at term [4].
Global incidence of preterm birth is around 9.6% of all
birth representing 12.9 million births [5] with regional
disparities: 12% to 13% in the USA, from 5% to 9% in
Europe [6], and 18% in Africa [7]. For ten years, the rate of
preterm birth does not decrease in most of the industrialized
countries. In the USA preterm birth prevalence increased
from 9.5% in 1981 to 12.7% in 2005. Furthermore, women
classiﬁed as black, Afro-American and Afro-Caribbean, are
frequently reported to be at higher risk of preterm birth
[7]. Preterm birth rates are in the range of 16–18% in
black women compared with 5–9% for white women in
USA [2]. Many preventive treatments have been proposed
to decrease risk of preterm birth especially for women
at risk. Many countries have programs oﬀering special
assistance to these women including advice and counseling
(about nutrition, drugs, tobacco), assistance (transportation
to clinic appointments, household help), and emotional
support [8]. Obstetric treatments are possible including
treatment with tocolytic agents, antenatal corticosteroids
and antibiotics, and optimum timing of indicated preterm
birth. These measures are intended to reduce the burden of
prematurity-related illness more than to reduce the rate of
preterm birth and have eﬀects on perinatal morbidity [9].
The role of many risk factors have been shown by results
of epidemiological studies such as increasing age of women
giving birth, ethnical origin, tobacco, socioeconomic dis-
parities, maternal body-mass index, or multiple pregnancies
[5, 10–12]. Mother’s health is also an important factor
inﬂuencing pregnancy outcome. Cervical incompetence or
short cervical length, preeclampsia and numerous maternal
infection, systemic like toxoplasmosis [13, 14] and local
infections such as bacterial vaginosis, chorioamnionitis, or
uterine track infections [2, 15–17] increase the risk of
preterm birth. Unfortunately, around 50% of causes of
preterm birth remain unknown [16]. In 1996, Oﬀenbacher
et al. introduced the hypothesis that periodontal diseases
could be a potential risk factor for preterm birth [18]. Since,2 Journal of Pregnancy
many epidemiological or interventional studies have been
performed to explore this relationship.
2. PeriodontalHealth andPregnancy:
AReciprocalRelationship
The periodontal diseases are inﬂammatory diseases of gum
and tooth supporting tissues caused by the oral bacterial
bioﬁlm containing almost 300 diﬀerent species [19–21].
Diﬀerent forms of periodontal diseases are observed. The
superﬁcial, reversible, and relatively harmless form corre-
sponds to the gingivitis, and the profound and irreversible
form corresponds to the periodontitis [20].
Gingivitisisacommonpathologythataﬀectseveryonein
his life (prevalence 80 to 100%). It corresponds to an inﬂam-
mation of superﬁcial soft tissues around teeth initiated by
supragingival bioﬁlms accumulation. The principal clinical
signsarebleedingduringtoothbrushingormastication,gum
swelling, and gingival pains. Gingivitis is due to an absence
or inappropriate oral hygiene habits and is worsened by local
factor increasing dental plaque retention including supra-
gingival calculus, retentive crown or dental misalignment,
and absence or irregular dental cares. Consequently, oral
hygiene education, scaling, and monitoring are very eﬃcient
to treat and prevent gingivitis [22].
The prevalence of periodontitis is about 60% with a pick
of incidence at 60 years [20]. Periodontitis correspond to
an inﬂammation of superﬁcial and profound periodontal
tissues caused by supra- and sub-gingival bioﬁlms and
leading to an irreversible destruction of tooth supporting
tissues. The pathognomonic clinical sign of periodontitis is
the formation of periodontal pockets. The others classical
associated signs are gingival bleeding, gingival retraction,
long appearance of teeth, tooth mobility, halitosis, abscess,
bone loss, tooth mobility, and in the most severe cases, spon-
taneous tooth loss [20]. Two principal forms of periodontitis
are recognized. The chronic form progresses slowly on many
decades and displays successive phases of activity. Older
patients may present severe form of chronic periodontitis
with a consequent bone loss. However, in patients suﬀering
from chronic periodontitis, the number of teeth lost for
periodontal reasons is generally low. The aggressive form
aﬀects less than 10% of the general population. This form
is predominant in young population and could lead to an
important loss of teeth in few years [23]. This form is
characterizedbyastronginﬂammatoryresponseandarapid,
profound, and generalized destruction of periodontal tissues
associatedtothepresenceofvirulentbacteriasuchasPorphy-
r o m o n a sg i n g i v a l i s( P g ) , Aggregatibacter actinomycetemcomi-
tans (Aa),a n dTreponema denticola [21] (Figure 1). Finally,
the evolutions of chronic and aggressive periodontitis and at
a lesser extent the evolution of gingivitis are markedly and
negatively inﬂuenced by many risk factors such as tobacco,
diabetes, low socioeconomic status, and ethnic origin. For
instance, Africans have a higher prevalence of aggressive
forms of periodontitis [24–26].
The diagnosis of gingivitis and periodontitis is generally
based on clinical symptoms described above; however, be
recognized by patient himself. Many studies based on self-
report have shown that patients were able to evaluate cor-
rectly but grossly their periodontal status [27]. However, the
evaluation of periodontitis severity requires a speciﬁc exam-
ination based at least on a periodontal probing performed
by a periodontist or a general dentist. The periodontal
pocket depth associated to gingival bleeding measurement
could be considered as the best markers of periodontal
disease activity or the inﬂammatory/infectious burden of
periodontitis. The measurement of clinical attachment level
(periodontal pocket depth plus gingival recession) and bone
loss around teeth reﬂect more the history and the severity of
periodontal disease.
The aim of periodontitis treatment is to reduce peri-
odontal tissues infection through a rigorous oral hygiene
education and a mechanic treatment (scaling, root planning,
and surgery) [20], associated to a chemical antimicrobial
therapy including the administration of systemic antibiotics
in the severe chronic or aggressive forms of periodontitis
[28]. Patients must also attend regular visits to dentist
or periodontologist to control and maintain periodontal
treatment results. These treatments decrease eﬃciently peri-
odontal tissue inﬂammation and eliminate the more virulent
periodontal pathogens. They stop the destruction of peri-
odontal tissues and prevent tooth loss [29–31]. Furthermore,
they improve some systemic conditions (glycemia, lipid
metabolism, endothelial function) [32–35]. However, the
initial severity of periodontitis and the persistence of risk
factors such as smoking and diabetes considerably impair
periodontal treatment results [31, 36].
Interestingly, pregnancy inﬂuenced also periodontal sta-
tus. Pregnant women are more susceptible to inﬂammation
and display an increase of gingival bleeding on probing.
Pregnantwomenpresentgenerallyperiodontalpocketdueto
gingival swelling rather than periodontal tissue breakdown
[37]. These periodontal pockets disappear after delivery.
However, in women suﬀering from periodontitis before
their pregnancy, it appears that pregnancy could lead to
an increase of periodontal disease severity [38]. Hormonal
modiﬁcations have been proposed to exacerbate gingival
inﬂammation, to initiate changes in the composition of oral
bioﬁlm, and to induce a selective growth of periodontal
pathogens such as Porphyromonas gingivalis, Prevotella inter-
media [39], or Campylobacter rectus [40].
3. Epidemiological Link
During the last decade, numerous epidemiological studies
have been conducted on the association between preterm
birth and periodontitis [3]. More or less strong associations
between periodontal status and preterm birth alone (PB),
low birth weight (LBW), or preterm birth associated to
low birth weight (PLBW) have been shown in cohort/cross-
sectional studies by Lunardelli and Peres [41]( B r a z i l ,P B
P<0.02), Oﬀenbacher et al. [42] (USA, PB P = 0.013),
L´ opez et al. [43]( C h i l e ,P L B WP<0.0004 and RR = 3.5),
Siqueira et al. [44]( B r a z i l ,P BP<0.001), Rajapakse et al.
[45]( S r iL a n k a ,P BO R= 2.3), Toygar et al. [46]( T u r k e y ,
PB and PLBW P<0.0 1 ) ,A g u e d ae ta l .[ 47] (Spain, PBJournal of Pregnancy 3
Figure 1: Clinical views of aggressive periodontitis aﬀecting pregnant women. Major clinical signs are gingival inﬂammation and alveolar
bone destruction. (Courtesy to Dr. Bouaziz W).
OR = 1.77), and Heimonen et al. [48] (Finland, PB P<
0.001), and also in case-control studies by Gomes-Filho et al.
[49]( B r a z i l ,P L B WO R= 2.1 ) ,a n dK h a d e re ta l .[ 50]( J o r -
dan, PLBW P<0.0001). However, some other investigations
did not ﬁnd a signiﬁcant association, such as cohort studies
by Moore et al. [51] (PB, LBW), Noack et al. [52]( G e r m a n y ,
PLBW),Aguedaetal.[47](PLBW),Nabetetal.[53](F rance,
PB), and case-control studies by Davenport et al. [54] (UK,
PLBW), Bassani et al. [55]( B r a z i l ,P L B W ) ,a n dV e t t o r ee ta l .
[56] (Brazil, PB, and PLBW). The diﬀerent conclusions of
these studies could be explained by the use of diﬀerent
deﬁnitions of adverse pregnancy outcomes, for instance PB
versus PLBW and periodontal disease deﬁnitions, reﬂecting
in fact diﬀerent pathologic entities and disease severities [57,
58]. Indeed, the periodontal status assessment of pregnant
women is mainly based on threshold numbers of sites
with prespeciﬁed values of periodontal pocket depth and/or
clinical attachment loss [41, 43, 47, 49, 59, 60] but could also
be determined by the use of other composite index such as
Community Periodontal Index forTreatment Need (CPITN)
[48, 54] or other clinical signs including bleeding on probing
[45]. Interestingly, the use of variable periodontitis deﬁni-
tions could reverse the association in some cases, especially
in cohort studies [56, 58]. However, a high prevalence of
severe periodontitis is frequently associated with PB and/or
LBW [44, 47, 49, 60, 61] while a low prevalence (7.2%) is not
[51]. Furthermore, the strength of the association between
periodontal disease and preterm birth incidence increases
frequently with the severity of periodontitis [7, 42, 49, 55,
58]. All these data suggest that women populations with a
high prevalenceof severeperiodontitis are at risk forpreterm
birth.
The risk factors of preterm birth appear to be similar
to risk factors for periodontal diseases (tobacco, ethnicity,
socioeconomic and educational levels) and may confound
the association between periodontitis and preterm birth
[3, 7, 62, 63]. Actually, smoking is recognized as one of the
principal risk factors for both adverse pregnancy outcomes
and periodontitis [17, 64]. In many studies evaluating
periodontal status eﬀect on pregnancy, the rate of smoking
among pregnant women oscillates between 10 and 20% [41,
42, 46, 49, 55, 56] and is frequently related to periodontitis
severity and/or preterm birth but not systematically. The
deﬁnition criterion of smoking habits and severity, such as
the number of cigarettes per day and period of smoking
(during and/or prior to pregnancy), vary greatly between
studies and may also explain these diﬀerent results [46,
61]. In some studies ethnicity is correlated with pregnancy
outcome and/or periodontal status [42, 51, 63] while other
investigations do not report such a correlation [54–56, 65].
In the same way, elevated percentages of pregnant women
with no education or only primary education are frequently
associated with PB and/or LBW [44, 46, 50]a n dp e r i o d o n -
titis [45], but not systematically [54, 55]. This diversity of
epidemiologic study results shows the interest to best deﬁne
the speciﬁcity of periodontal pathology of pregnant women
considering their young age and the hormonal inﬂuence of
pregnancy on periodontal tissues.
4.Biological Hypothesis
Considering epidemiological evidence, biological theories
have been proposed to link preterm birth and periodontal
diseases [66]. Mainly, three hypotheses are developed
(i) bacterial spreading,
(ii) inﬂammatory products dissemination,
(iii) role of feto-maternal immune response against oral
pathogens.4 Journal of Pregnancy
4.1. Bacterial Spreading. The current paradigm indicates
that majority of intrauterine infection originates in the
lower genital tract [67]. Despite this statement, number
of studies report intrauterine infections caused by species
not found in urogenital tract [67]. The bacterial spreading
theory is based on the possible dissemination of oral bacteria
including periodontal pathogens through blood circulation
[68] to the amniotic ﬂuid and leading to chorioamniotic
infections. The frequent gingival inﬂammation of women
presenting periodontal diseases [69], especially pregnancy-
associated gingivitis [70], facilitates bacteremia process [67].
Furthermore, the more periodontal pockets are deep, the
more important is the exchange surface between bacteria
bioﬁlm and blood circulation (15 to 20cm2 in the most
severe cases) [71]. Many analyses of amniotic ﬂuid or
placenta have been performed and evidence the presence
of diﬀerent oral pathogens such as Bergeyella, Eikenella
[67], Fusobacterium nucleatum, or Porphyromonas gingi-
valis [72–74]. Inside uterus, these pathogens could pro-
voke an inﬂammatory response. The increase of inﬂam-
matory cytokines or metalloproteases synthesis and the
neutrophil activation could induce preterm birth process
[67].
In vivo studies show that the invasiveness of uterine
tissues largely depends on the type of bacteria. In a sheep
modelofintra-amnioticinjectionoflipopolysaccharidefrom
diﬀerent bacterial species, it appears that periodontopathic
lipopolysaccharides induce a high rate of fetal lethality
[75]. Furthermore, in a rat model, placenta colonization
by Porphyromonas gingivalis is dose and strain dependent
[76]. Potential pathological mechanisms of certain peri-
opathogens, especially for Porphyromonas gingivalis and
Fusobacterium nucleatum, have been studied. For example,
Porphyromonas gingivalis could infect syncytiotrophoblasts,
chorionic trophoblasts, decidual cells, and amniotic epithe-
lial cells [74] and promotes inﬂammatory process trough
Toll-like receptor 4 [77].
Finally, a case-report study has been published in 2010
concerning a stillbirth caused by Fusobacterium nucleatum
from the mother’s mouth [78]. This study highlights the
fact that an oral periodontal pathogen can, by hematologic
pathway, colonize placenta and provoke fetal complications.
It is important to notice that such colonization may be
dependant from mother’s immunological status.
4.2. Hematogenous Dissemination of Inﬂammatory Products.
Acute inﬂammation is responsible for a substantial fraction
of preterm birth [79]. In 1998, Oﬀenbacher et al. suggested
that the cytokines produced by local inﬂammation in
periodontal tissues aﬀected by periodontitis have systemic
eﬀects after diﬀusion of such cytokines through blood ﬂow
[80]. Locally, studies show that periodontal diseases increase
secretion of several cytokines, notably PGE-2, TNF-α,I L - 6
or IL-1β [81, 82]. Analysis of amniotic ﬂuid obtained at the
time of preterm birth shows elevated levels of inﬂammatory
cytokines [83]. We hypothesize that cytokines produced
in periodontal tissues promote inﬂammation in maternal-
fetal unit. Clinically, high gingival crevicular ﬂuid levels of
PGE-2,IL-1β,orIl-6havebeenassociatedwiththeirelevated
levels in amniotic ﬂuid [80, 84]. The inﬂammatory response
appears to be the privileged pathway of the pathogenic
periodontal disease inﬂuence on pregnancy, as suggested
for other major systemic diseases including cardiovascular
diseases or diabetes [85].
4.3. Fetomaternal Immune Response. T h ei m m u n ea n d
genetic characteristics of fetus and pregnant women are one
of the potential mechanisms linking periodontal diseases to
preterm birth. Numerous studies have analyzed fetal and
maternal antibodies directed against oral pathogens during
pregnancy. In the study of Boggess et al., 35.2% of samples
are Ig-M positive for at least one oral pathogen, and 26.6%
are positive for more than one. The presence of Ig-M is
associated to an increased risk of preterm birth [86]. This
immune response against oral pathogens could be associated
with an inﬂammatory response, and the synergy between
the two mechanisms increases signiﬁcantly the risk [86]. The
genetic predisposition is also important. Polymorphisms of
genes coding for proinﬂammatory cytokines such as TNF-α,
IL-1 or IL-6 are associated to a hyperinﬂammatory response.
The consecutive overexpression of these cytokines increases
the risk of preterm birth [87–89].
The mechanisms linking periodontal diseases and
preterm birth are not well deﬁned. Further investigations
should be performed to evaluate the impact of each the-
ory. Nevertheless, we hypothesized that the inﬂuence of
periodontal diseases on preterm birth is the result of an
inﬂammation of the fetomaternal unit that is ampliﬁed in
women presenting particular phenotype.
5. Effects of Periodontal Treatment on
PretermBirth Incidence
Considering periodontal diseases as a risk factor for preterm
birth,interventionalstudieshavebeenperformedtoevaluate
impact of periodontal treatment on pregnancy outcomes.
Case-control studies including a relative large number of
pregnant women (>400) show some apparent contradictory
results and diﬀerent conclusions [43, 90–94]. Indeed, the
periodontal treatment may improve periodontal conditions
and/or pregnancy outcomes [43, 90, 94]o rn o t[ 91, 93].
A recent meta-analysis indicates that the treatment of
periodontal diseases does not reduce the rate of preterm
birth [95]. However, as discussed above for epidemiological
studies, the conclusions of this analysis could be balanced by
the relative heterogeneity of studied populations, according
to risk factors ethnicity, smoking, socioeducative levels, and
periodontal status deﬁnition. For instance, the percentage
of black people varies considerably between studies: 50%
to 65% of Hispanic and Caucasian [38, 43]); 45% to 87%
of Afro-American [90, 93]. Furthermore, the modalities
of periodontal care in the diﬀerent studies display some
diﬀerences that may inﬂuence periodontal outcomes. A
ﬁrst session of etiologic periodontal treatment, including
oral hygiene instructions, scaling, and root planning was
generally performed at the end of the ﬁrst trimester ofJournal of Pregnancy 5
pregnancy (before 20 to 28 weeks). This ﬁrst session could
be unique [91, 93] or reinforced by regular control visits and
complementary treatments if necessary until delivery [43,
90]. The local eﬀects of periodontal treatments are generally
positive [43, 90]. Gingival inﬂammation and mean probing
pocket depth are reduced, especially in study using rein-
forced periodontal treatment modalities [43, 90]. However,
a relative high rate of patients demonstrating a periodontitis
progression is observed in some studies (70% [91], 50%
[90], 68% [94]) suggesting that periodontal treatments
do not work so eﬃciently than in a general population
[91]. Indeed, the relative “narrow therapeutic window” to
perform periodontal treatment and to obtain a successful
periodontal lesion cicatrisation, and the aggressive proﬁle of
severe periodontitis in young women could be considered
as limiting factors [91, 94]. A recent study performed by
Jeﬀcoat et al. [94] conﬁrms that the eﬃciency of periodontal
treatment should be considered before the analysis of results.
In this study, 322 pregnant women with periodontal disease
have been followed, 160 have received randomly complete
periodontal treatment, and 162 have served as control
without treatment. No signiﬁcant diﬀerence was found in
term of preterm birth incidence between the two groups.
However, after considering the eﬀect of periodontal therapy,
the results demonstrate a strong and signiﬁcant relationship
betweensuccessfulperiodontaltreatmentandfull-termbirth
ratio (odds ratio = 6.02) [94].
Despite apparent conﬂicting data, the majority of studies
reportthatperiodontaltreatmentissafeforpregnantwomen
and improve periodontal status [3, 90, 92, 94]. The pregnant
woman is a particular patient. In order to decrease the
impact of periodontal disease on preterm birth incidence,
the early diagnosis promotion of periodontal disease for
young women especially for those presenting major risk
factors should be recommended. The preventive oral care
is the best way to prevent oral diseases and their conse-
quences on pregnancy [96]. In case of periodontal disease
diagnosis done during pregnancy, a frequent monitoring
of the patient should be positive for the control of the
disease and the decrease of preterm birth risk. For severe
or aggressive periodontitis, metronidazole or amoxicillin
could be used in addition to mechanical treatments. Studies
have been performed on the eﬀect of antibiotic on rate of
preterm birth concerning bacterial vaginosis. The majority
of them demonstrates no deleterious eﬀect of antibiotic
use on pregnancy outcome especially for metronidazole
[97].
6. Conclusion
Periodontal diseases appear to be a potential risk factor
for preterm birth. As well as other modiﬁable risk factors,
these diseases must be taken in charge. Cooperation between
obstetricians or general practitioners and periodontists
should be developed. The promotion of the early detection
and treatments of periodontal disease in young women
before and during pregnancy will be beneﬁcial especially for
women at risk.
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